Lutetium (177Lu) rhPSMA-10.1 injection
BET-PSMA-121
Phase 2 small_molecule active
Quick answer
Lutetium (177Lu) rhPSMA-10.1 injection for Metastatic castration-resistant prostate cancer (mCRPC) is a Phase 2 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blue Earth Diagnostics Ireland Ltd
- Indication
- Metastatic castration-resistant prostate cancer (mCRPC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active